Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Truvaga is a consumer health company specializing in non-invasive vagus nerve stimulation (nVNS) technology designed to improve wellness and mental health. As a brand of electroCore, the company offers handheld devices that deliver gentle electrical signals to the vagus nerve, aiming to reduce stress, enhance sleep quality, and improve mental clarity. The technology is based on clinically proven bioelectronic medicine originally developed for medical-grade applications. Truvaga's products, such as Truvaga Plus, provide a drug-free alternative for individuals seeking to balance their nervous system and manage daily stressors. The company focuses on making advanced neurostimulation accessible to the general public for everyday use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Truvaga.